ISRCTN55293778已完成不适用
Pre and post operative chemotherapy with oxaliplatin, 5-Fluorouracil (5 FU)/Leucovorin (LV) versus surgery alone in resectable liver metastases from colorectal origi
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 363 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 363
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All potentially resectable liver metastases without detectable extra-hepatic tumour
- •2. Primary tumour resected or resectable
- •3. No previous chemotherapy with oxaliplatin
排除标准
- •Not provided at time of registration
研究者
相似试验
招募中
2 期
eoadjuvant Chemotherapy with Oxaliplatin plus Fluorouracil l-Leucovorin or Oxaliplatin plus Capecitabin and MoAb for resectable colorectal liver metastases(CML) from tokai digestive cancer trials groupResectable Liver Metastases From Colorectal CancerJPRN-UMIN000003796Epidemiological and Clinical Research Information Network45
已完成
2 期
Treatment using Oxaliplatin and S-1 Adjuvant chemotherapy for Stage III gastric cancer trialGastric cancerJPRN-UMIN000025824Department of Surgery, Kochi Medical School75
已完成
2 期
Gunma study - Oxaliplatin-based chemotherapy and Avastin following Irinotecan-based chemotherapy with Erbitux in metastatic colorectal cancerMetastatic colorectal cancerJPRN-UMIN000007117Gunma University Graduate school of Medicine Department of General surgical science clinical study group53
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
进行中（未招募）
1 期
Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction.ocally advanced carcinoma (squamous or adenocarcinoma) of the esophago-gastric junction Siewert type I and IIMedDRA version: 14.1Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 100000004864EUCTR2013-001630-18-ITIstituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione G.Pascale”40